Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00097305 · ClinicalTrials.gov registry record · Phase 2
Body-Oriented Therapy for Sexual Abuse Recovery
A Phase 2 study of Post Traumatic Stress Disorder and Dissociation, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00097305 is a Phase 2 study of Post Traumatic Stress Disorder and Dissociation that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 24 participants, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00097305, a Phase 2 study of Post Traumatic Stress Disorder and Dissociation, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine and compare the effects of two body therapy approaches in women who have experienced child sexual abuse.
Conditions Studied
Interventions
- BEHAVIORAL Body-Oriented Therapy
- BEHAVIORAL Standardized Massage Therapy
Study Locations (1)
Washington
- University of Washington School of Nursing - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2002-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00097305
The ClinicalTrials.gov registry entry for NCT00097305 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (98% lower). The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Body-Oriented Therapy is the first listed.
NCT00097305 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00097305 about?
NCT00097305 is a clinical study titled "Body-Oriented Therapy for Sexual Abuse Recovery". The purpose of this study is to examine and compare the effects of two body therapy approaches in women who have experienced child sexual abuse.
What is the current status of trial NCT00097305?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2002-09.
What conditions does trial NCT00097305 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Dissociation, Child Abuse, Sexual.
What interventions are being tested in trial NCT00097305?
The interventions under investigation include: Body-Oriented Therapy (BEHAVIORAL), Standardized Massage Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00097305?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00097305 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine
RECRUITING · Phase 2
-
Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD.
RECRUITING · Phase 2
-
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
RECRUITING · Phase 2
-
Department of Defense PTSD Adaptive Platform Trial - Master Protocol
RECRUITING · Phase 2
-
MDMA for AUD/PTSD Comorbidity
RECRUITING · Phase 2
-
Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.